These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17652525)

  • 21. Persistence of anti-West Nile virus-specific antibodies among asymptomatic blood donors in northeastern Italy.
    Pierro A; Gaibani P; Manisera C; Rossini G; Finarelli AC; Ghinelli F; Macini P; Landini MP; Sambri V
    Vector Borne Zoonotic Dis; 2013 Dec; 13(12):892-3. PubMed ID: 23919606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. West Nile virus among blood donors in the United States, 2003 and 2004.
    Stramer SL; Fang CT; Foster GA; Wagner AG; Brodsky JP; Dodd RY
    N Engl J Med; 2005 Aug; 353(5):451-9. PubMed ID: 16079368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cases of West Nile Virus infection in north-eastern Italy, 15 June to 15 November 2010.
    Barzon L; Pacenti M; Cusinato R; Cattai M; Franchin E; Pagni S; Martello T; Bressan S; Squarzon L; Cattelan A; Pellizzer G; Scotton P; Beltrame A; Gobbi F; Bisoffi Z; Russo F; Palu G
    Euro Surveill; 2011 Aug; 16(33):. PubMed ID: 21871228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus.
    Papa A; Karabaxoglou D; Kansouzidou A
    J Med Virol; 2011 Oct; 83(10):1861-5. PubMed ID: 21837806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of West Nile virus seroprevalence in healthy blood donors].
    Hızel K; Yenicesu I; Erdal B; Yeşilyurt E; Fidan I; Kalkancı A; Dilsiz G
    Mikrobiyol Bul; 2010 Jul; 44(3):425-30. PubMed ID: 21063992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. West Nile viremic blood donors and risk factors for subsequent West Nile fever.
    Brown JA; Factor DL; Tkachenko N; Templeton SM; Crall ND; Pape WJ; Bauer MJ; Ambruso DR; Dickey WC; Marfin AA
    Vector Borne Zoonotic Dis; 2007; 7(4):479-88. PubMed ID: 17979539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
    Tobler LH; Bianco C; Glynn SA; Schreiber GB; Dille BJ; Prince HE; Lanciotti RS; Linnen JM; Gallarda J; Shyamala V; Smith D; Kleinman SH; Busch MP;
    Transfusion; 2005 Apr; 45(4):480-6. PubMed ID: 15819666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.
    Prince HE; Lapé-Nixon M; Busch MP; Tobler LH; Foster GA; Stramer SL
    Clin Diagn Lab Immunol; 2005 Sep; 12(9):1123-6. PubMed ID: 16148183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. West Nile virus blood transfusion-related infection despite nucleic acid testing.
    Macedo de Oliveira A; Beecham BD; Montgomery SP; Lanciotti RS; Linnen JM; Giachetti C; Pietrelli LA; Stramer SL; Safranek TJ
    Transfusion; 2004 Dec; 44(12):1695-9. PubMed ID: 15584982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases.
    Roehrig JT; Nash D; Maldin B; Labowitz A; Martin DA; Lanciotti RS; Campbell GL
    Emerg Infect Dis; 2003 Mar; 9(3):376-9. PubMed ID: 12643836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection.
    Ratterree MS; Gutierrez RA; Travassos da Rosa AP; Dille BJ; Beasley DW; Bohm RP; Desai SM; Didier PJ; Bikenmeyer LG; Dawson GJ; Leary TP; Schochetman G; Phillippi-Falkenstein K; Arroyo J; Barrett AD; Tesh RB
    J Infect Dis; 2004 Feb; 189(4):669-76. PubMed ID: 14767821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009.
    Pezzotti P; Piovesan C; Barzon L; Cusinato R; Cattai M; Pacenti M; Piazza A; Franchin E; Pagni S; Bressan S; Martello T; Potenza R; Scipioni C; Ammendola R; Breda A; Palu G; Russo F; Rezza G
    Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to equine IgM improve the sensitivity of West Nile virus-specific IgM detection in horses.
    Wagner B; Glaser A; Hillegas JM; Erb H; Gold C; Freer H
    Vet Immunol Immunopathol; 2008 Mar; 122(1-2):46-56. PubMed ID: 18054390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.
    Levett PN; Sonnenberg K; Sidaway F; Shead S; Niedrig M; Steinhagen K; Horsman GB; Drebot MA
    J Clin Microbiol; 2005 Dec; 43(12):5873-5. PubMed ID: 16333069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a new West Nile Virus lateral-flow rapid IgM assay.
    Sambol AR; Hinrichs SH
    J Virol Methods; 2009 May; 157(2):223-6. PubMed ID: 19138705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of factors associated with positive IgM capture ELISA results in equids with clinical signs compatible with West Nile virus infection: 1,017 cases (2003).
    Tanner JM; Traub-Dargatz JL; Hill AE; Van Campen H; Knight AP; Cunningham WE; Salman MD
    J Am Vet Med Assoc; 2006 Feb; 228(3):414-21. PubMed ID: 16448369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.
    Rios M; Daniel S; Dayton AI; Wood O; Hewlett IK; Epstein JS; Caglioti S; Stramer SL
    J Infect Dis; 2008 Nov; 198(9):1300-8. PubMed ID: 18771407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection.
    Vilibic-Cavlek T; Kristofic B; Savic V; Kolaric B; Barbic L; Tabain I; Peric L; Sabadi D; Miklausic B; Potocnik-Hunjadi T; Zember S; Stevanovic V; Listes E; Savini G
    Rev Soc Bras Med Trop; 2018; 51(5):591-595. PubMed ID: 30304263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
    Kleinman S; Glynn SA; Busch M; Todd D; Powell L; Pietrelli L; Nemo G; Schreiber G; Bianco C; Katz L;
    Transfusion; 2005 Apr; 45(4):469-79. PubMed ID: 15819665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.